As a provider of portable oxygen concentrators, SeQual will complement and broaden Caire’s respiratory portfolio by creating a one-stop-shop for a provider’s oxygen needs.

SeQual Technologies CEO and president Ron Richard said that Chart’s years of industry experience, financial stability and global presence will allow SeQual to focus on providing solutions for the oxygen segment of health care.

"With over 40,000 eclipses deployed throughout the world, SeQual is a proven provider in long-term oxygen therapy and prides itself on clinical efficacy and education," Richard said.

Chart BioMedical Steve Shaw president said this transaction combines SeQual’s technology and patient-focused product development capabilities with their global marketing, distribution and operating expertise and they expect to integrate the majority of SeQual’s operations during 2011.